Not Yet Recruiting NA INTERVENTIONAL 3-arm NCT07134660

Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine

Analgesic Efficacy Between Liposomal Bupivacaine and Bupivacaine Hydrochloride in Intercostal Nerve Block for Thoracic Surgery: A Multicenter Randomized Controlled Trial

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Conditions Lung Cancer Postoperative Pain, Acute

Interventions Bupivacaine Hydrochloride intercostal nerve block Liposomal Bupivacaine intercostal nerve block Standard Postoperative Analgesia

Updated 2 times since 2025 Last updated: Aug 28, 2025 Started: Sep 1, 2025 Primary completion: Dec 15, 2025 Completion: Dec 20, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Lung Cancer and Postoperative Pain, Acute and is currently actively recruiting participants. Shanghai Pulmonary Hospital, Shanghai, China leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

2 versions recorded

Oct 2025 — Present [monthly]

Not Yet Recruiting NA
Sep 2025 — Oct 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Pulmonary Hospital, Shanghai, China

Data source: Shanghai Pulmonary Hospital, Shanghai, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.